yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologai - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.
remolexam
vital pharma gmbh - meloksikamas - injekcinis tirpalas - 7,5 mg; 15 mg/1,5 ml - meloxicam
spironolactone accord
accord healthcare b.v. - spironolaktonas - plėvele dengtos tabletės - 100 mg; 25 mg; 50 mg - spironolactone
donerion
orion corporation - donepezilo hidrochloridas - plėvele dengtos tabletės - 5 mg - donepezil
donerion
orion corporation - donepezilo hidrochloridas - plėvele dengtos tabletės - 10 mg - donepezil
nitigraf
juste s. a. q. f - joheksolis - injekcinis tirpalas - 755 mg/ml; 647 mg/ml - iohexol
normosang
recordati rare diseases - Žmogaus heminas - koncentratas infuziniam tirpalui - 25 mg/ml - heme products
seduxen
gedeon richter plc - diazepamas - tabletės - 5 mg - diazepam
tisercin
egis pharmaceuticals plc - levomepromazinas - plėvele dengtos tabletės - 25 mg/ml; 25 mg - levomepromazine
anefaltic
sanoswiss, uab - nefopamo hidrochloridas - plėvele dengtos tabletės - 30 mg - nefopam